菌体疗法可以安全有效地对抗抗药性泛型菌菌的感染
Wei-Xiao Wang1, Jia-Zhen Wu2, Bai-Ling Zhang3
1Clinical Research Center, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
International journal of antimicrobial agents
|May 29, 2024
概括
使用FAb4B的菌体治疗有效地对抗Acinetobacter baumannii生物膜和感染. 与西普罗夫洛克萨的联合治疗在临床前模型中显著提高了存活率,显示出对抗微生物耐药性的承诺.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 抗菌素耐药性 (AMR) 需要新的治疗策略.
- 菌体治疗为传统抗生素提供了一个可行的替代方案.
- 了解菌体的有效性和安全性对于临床转化至关重要.
研究的目的:
- 为了评估一种新型菌体的疗效,FAb4B,对抗Acinetobacter baumannii.
- 为了研究FAb4B与抗生素的协同作用.
- 在体内评估菌体治疗的安全性和治疗潜力.
主要方法:
- 在体外评估FAb4B对生物膜的活性.
- 在体内研究使用Acinetobacter baumannii bacteremia的小鼠模型.
- 对菌体-抗生素协同作用和毒性概况的评估.
主要成果:
- ФAb4B 抑制和根除了 Acinetobacter baumannii 的生物膜.
- 在小鼠中,法-西普罗夫洛克萨联合治疗实现了91%的存活率.
- 菌体治疗在体内证明安全,没有观察到急性毒性.
- 没有观察到细菌对菌体的耐药性是治疗失败的原因.
结论:
- 性菌体FAb4B对Acinetobacter baumannii有效,包括泛耐药菌株.
- 使用FAb4B和西普罗撒的联合治疗提供了对抗A. baumannii感染的有效策略.
- 这项研究为推进细菌感染的菌体治疗提供了强有力的临床前基础.
关键词:
这种细菌是Acinetobacter baumannii.在这种情况下,细菌血症.血液常规检查 血液常规检查增强注射的注入.组合疗法是一种组合疗法.作为一个中性粒细胞.菌体疗法是一种菌体疗法.预防性使用 预防性使用协同效应是一种协同效应.更多相关视频
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
584
07:22Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
2.9K
相关概念视频
01:30Lytic Cycle of Bacteriophages
70.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.6K
01:28Pneumonia IV: Management
322
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
322
01:31Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
01:27Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
368
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
368
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K